News & Articles

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

Scientific, technological and communications excellence has been celebrated at the Drug Discovery & Development Webinar Series, with Waters, BioTek and PHCbi among those recognized

Gang Chen, lab manager at Simon Fraser University, reveals his contribution to tackling the pandemic and how communication is vital in science

The company will receive up to $5 million in grant funds from DARPA as part of the agency’s Nucleic Acids On-Demand World-Wide Program to plan for and prevent the next viral pandemic

The study reports on the enhancement of skin permeability of risperidone (RIS) using eutectic systems

Take a look at what other researchers and scientists are saying about cutting-edge technologies in drug discovery

Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications

Explore topics from AAV gene therapy and food fraud advances to LC-MS and Raman spectroscopy for drug discovery

The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway

Explore exclusive interviews and the latest resources to support your drug discovery workflows, from chemical imaging and fragment screening to assay development and gene therapy

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

OCREVUS significantly slowed loss of brain tissue within T2 MRI lesions in primary progressive multiple sclerosis (PPMS) in post-hoc analysis of Phase III ORATORIO study

The modular, automated 3D cell culture and image analysis lab enables customers to streamline and scale organoid interrogation, advancing drug discovery research

Virender Singh shares his work, his average day, and favorite piece of laboratory equipment

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

A response to the unprecedented global demand for key scientific resources

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing